See also this year's filing and all EDGAR filings for this company.
PDF Report 0001582313_2018_Xenon_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001582313, Xenon Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 44,821,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,070,000 |
| 3 | remainder_Assets | 230,000 |
| 4 | LiabilitiesCurrent | 4,083,000 |
| 5 | LiabilitiesNoncurrent | 6,104,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,313,000 |
| 9 | ResearchAndDevelopmentExpense | 25,573,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 311,000 |
| 12 | remainder_NetIncome | 1,871,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 46,121,000 |
| 1 | Liabilities | 10,187,000 |
| 2 | Expenses | 32,886,000 |
| 3 | Revenues | 311,000 |
| 4 | StockholdersEquity | 35,934,000 |
| 5 | NetIncome | -30,704,000 |
| 6 | ComprehensiveNetIncome | -30,704,000 |
| 7 | BaseVar | 45,688,000 |
| 8 | EconomicCapitalRatio | 1.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
